Work

A High-Throughput Drug Screen Reveals a Novel Compound Class That Significantly Depletes IRF4 Expression in Multiple Myeloma

Year: 2019

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2019-130910

Authors: Elizabeth D. Lightbody, Mairead Reidy, Michael P. Agius, Salma El-Behaedi, Romanos Sklavenitis-Pistofidis, Salomon Manier, Irene M. Ghobrial

Institutions: Harvard University, Dana-Farber Cancer Institute, Broad Institute, Inserm, Université de Lille, Centre Hospitalier Universitaire de Lille

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2987205139

Cites:

Cited by: 2

Related to: 10